More recently described PINK1/Parkin mitophagy activators, identified through high-throughput screening, computational simulation-based screens and other efforts provide attractive avenues for the development of PINK1/Parkin based PD therapeutics [96,97,100] (Table 1). The gene discussed is PINK1; the disease is Parkinson disease.